Write For Us

Affordable & Scalable | High-precision antibody test & promising alternative vaccine for COVID-19

E-Commerce Solutions SEO Solutions Marketing Solutions
162 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
In part 2 of this special edition episode, Tony – along with his friend Dr. Peter Diamandis, the Harvard Medical School trained M.D. and executive founder of Singularity University – explore the present and future of COVID-19.
Tony and Peter speak with Mei Mei Hu and Lou Reese, Co-CEOs of United Biomedical, a company that is now offering an affordable and accurate diagnostic test for COVID-19 through its subsidiary, COVAXX

Their antibody test is different from others, as it can detect not only if you currently have the virus, but also it signals if you’ve ever had the virus, which is crucial in determining the true rate of mortality associated with COVID-19 – and whether people are immune and therefore able to stop isolating, and go back to work.

Lou and Mei Mei’s team at COVAXX is also working on a breakthrough alternative option to a traditional vaccine for coronavirus, which you’ll hear discussed in the last half of the episode.

COVAXX: https://www.covaxx.com/

View Part One Here: https://youtu.be/mR6rAUcYmTA

Get a FREE copy of Unshakable : https://www.unshakeable.com/

Follow TR:
Facebook: https://www.facebook.com/TonyRobbins
Twitter: https://twitter.com/tonyrobbins
LinkedIn: https://www.linkedin.com/in/ajrobbins
Instagram: https://instagram.com/tonyrobbins/
Website: https://www.tonyrobbins.com/

Tony Robbins is a #1 New York Times best-selling author, entrepreneur, and philanthropist. For more than 37 years, millions of people have enjoyed the warmth, humor and dynamic presentation of Mr. Robbins' corporate and personal development events. As the nation's #1 life and business strategist, he's called upon to consult and coach some of the world's finest athletes, entertainers, Fortune 500 CEOs, and even presidents of nations.
Category
Success
Sign in or sign up to post comments.
Be the first to comment